Elmar Schärli active positions
| Companies | Position | Start | End |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Director of Finance/CFO | - | - |
Zilentin AG
 Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Director/Board Member | - | - |
Career history of Elmar Schärli
Former positions of Elmar Schärli
| Companies | Position | Start | End |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Director of Finance/CFO | 2019-10-31 | 2021-10-31 |
Statistics
International
| Switzerland | 3 |
| Bermuda | 2 |
Operational
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Elmar Schärli
- Experience
